Shinohara Fumiaki

シノハラフミアキ | Shinohara Fumiaki

Affiliation and department：
Homepage URL (1)： http://db.tohoku.ac.jp/whois/detail/54cf707cc460bc8d6a46a7e4680ee813.html
Research theme for competitive and other funds (3)：

2011 - 2013 Analysis of sensitivity of oral cancer to Cetuximab and gene modification of KRAS, BRAF and PIK3CA in OSCC.
2009 - 2010 Epigenetic regulation of VEGF-C/-D in cervical lymph node metastasis.
2007 - 2008 Suppression of angiogenesis and metastasis on OSCC using epigenetical agents.

Papers (3)：

Hiroyuki Kanzaki, Fumiaki Shinohara, Mikihito Kajiya, Sari Fukaya, Yutaka Miyamoto, Yoshiki Nakamura. Nuclear Nrf2 Induction by Protein Transduction Attenuates Osteoclastogenesis. FREE RADICAL BIOLOGY AND MEDICINE. 2014. 77. 239-248
Hiroyuki Kanzaki, Fumiaki Shinohara, Mikihito Kajiya, Tetsuya Kodama. The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species Signaling. JOURNAL OF BIOLOGICAL CHEMISTRY. 2013. 288. 32. 23009-23020
Maiko Suzuki, Fumiaki Shinohara, Hidemi Rikiishi. Zebularine-induced reduction in VEGF secretion by HIF-1 alpha degradation in oral squamous cell carcinoma. MOLECULAR MEDICINE REPORTS. 2008. 1. 4. 465-471

MISC (26)：

Maiko Suzuki, Manabu Endo, Fumiaki Shinohara, Seishi Echigo, Hidemi Rikiishi. Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2011. 67. 5. 1129-1136
Maiko Suzuki, Manabu Endo, Fumiaki Shinohara, Seishi Echigo, Hidemi Rikiishi. Differential apoptotic response of human cancer cells to organoselenium compounds. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2010. 66. 3. 475-484
Maiko Suzuki, Manabu Endo, Fumiaki Shinohara, Seishi Echigo, Hidemi Rikiishi. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2009. 64. 6. 1115-1122
Maiko Suzuki, Fumiaki Shinohara, Manabu Endo, Masaki Sugazaki, Seishi Echigo, Hidemi Rikiishi. Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2009. 64. 2. 223-232
Maiko Suzuki, Fumiaki Shinohara, Hidemi Rikiishi. Zebularine-induced reduction in VEGF secretion by HIF-1 alpha degradation in oral squamous cell carcinoma. MOLECULAR MEDICINE REPORTS. 2008. 1. 4. 465-471

ｍore...

Professional career (1)：

博士 (東北大学大学院歯学研究科)

Work history (1)：

Tohoku University Dental Hospital, Department of Oral and Maxillfaocial Surgery Assistant Professor

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page